{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:55:28Z","timestamp":1792612528771,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Although polycystic ovary syndrome (PCOS) is a very common endocrinopathy, there are several issues related to this disorder which perplex clinicians in their everyday practice.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine the current state of knowledge among European endocrinologists concerning the full spectrum of PCOS.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n An online survey comprising 41 items covering various aspects of PCOS diagnosis and management was distributed to members of the European Society of Endocrinology.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 505 European endocrinologists (64% females), with a mean age of 47 \u00b1 11.6 years, participated in the survey. The Rotterdam criteria were the primary diagnostic tool for 85% of respondents. Most referrals (87.1%) occurred between ages 20 and 40 years. Twenty-five percent of physicians have access to mass spectrometry for the evaluation of androgen levels. While an extended metabolic profile was commonly employed as part of the workup, there was uncertainty regarding chronic anovulation diagnosis. Diabetes, including gestational or type 2, was recognized as a significant risk factor with universal screening irrespective of BMI status. Lifestyle modification and metformin were considered as standard interventions by all participants alongside oral contraceptives, though there was significant discrepancy in treatment duration.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The Rotterdam diagnostic criteria are widely adopted for PCOS diagnosis among European endocrinologists. The current updated survey shows an emphasis on steroid profiling as an important part of diagnostic workup and a strong position held for recognition of PCOS as a metabolic condition with potentially serious implications. Current therapy thus shifted to the demand for prioritizing lifestyle interventions and metabolic therapies, either as monotherapy or in combination with standard hormone compounds.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae085","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T06:31:44Z","timestamp":1722839504000},"page":"134-143","source":"Crossref","is-referenced-by-count":9,"title":["European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-1521","authenticated-orcid":false,"given":"Sarantis","family":"Livadas","sequence":"first","affiliation":[{"name":"Endocrine Unit, Athens Medical Centre , 65403 Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent O","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine , Ankara 06100 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion Hospital, Faculty of Medicine, National and Kapodistrian University of Athens , 11528 Athens , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna , 40138 Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duarte","family":"Pignatelli","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Centro Hospitalar Universit\u00e1rio S. Jo\u00e3o and Faculty of Medicine of the University of Porto , 4200 \u2013 319 Porto , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-2678","authenticated-orcid":false,"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[{"name":"Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro , 70121 Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital , 5000 Odense , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Innere Medizin, Klinische Abteilung Endokrinologie und Diabetologie und Universit\u00e4tsklinik f\u00fcr Frauenheilkunde & Geburtshilfe Medizinische Universit\u00e4t Graz , 8036 Graz , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, Faculty of Medicine, University of Belgrade , 11000 Belgrade , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESE PCOS Special Interest Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent O","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duarte","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Skovsager","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarantis","family":"Livadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"2024082910341444600_lvae085-B1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2022.10.020","article-title":"Prevalence of polycystic ovary syndrome in European countries and USA: a systematic review and meta-analysis","volume":"279","author":"Chiaffarino","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2024082910341444600_lvae085-B2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","article-title":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017","volume":"36","author":"Liu","year":"2021","journal-title":"Hum Reprod"},{"issue":"3","key":"2024082910341444600_lvae085-B3","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024082910341444600_lvae085-B4","first-page":"94","article-title":"Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers","volume":"3","author":"Lee","year":"2022","journal-title":"F S Rep"},{"issue":"3","key":"2024082910341444600_lvae085-B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-13-1007","article-title":"Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome","volume":"171","author":"Livadas","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024082910341444600_lvae085-B6","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2024082910341444600_lvae085-B7","first-page":"76","article-title":"Barriers and facilitators to the implementation of evidence-based lifestyle management in polycystic ovary syndrome: a narrative review","volume":"7","author":"Blackshaw","year":"2019","journal-title":"Med Sci (Basel)"},{"issue":"3","key":"2024082910341444600_lvae085-B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2265.2004.02208.x","article-title":"Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management","volume":"62","author":"Cussons","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024082910341444600_lvae085-B9","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2024082910341444600_lvae085-B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.maturitas.2020.05.013","article-title":"Polycystic ovary syndrome and aging: health implications after menopause","volume":"139","author":"Helvaci","year":"2020","journal-title":"Maturitas"},{"issue":"4","key":"2024082910341444600_lvae085-B11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-14-0252","article-title":"European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024082910341444600_lvae085-B12","doi-asserted-by":"crossref","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PLoS Med"},{"issue":"7","key":"2024082910341444600_lvae085-B13","doi-asserted-by":"crossref","first-page":"e220536","DOI":"10.1530\/EC-22-0536","article-title":"Efficacy of very low-calorie ketogenic diet with the Pronokal\u00ae method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial","volume":"12","author":"Pandurevic","year":"2023","journal-title":"Endocr Connect"},{"issue":"3","key":"2024082910341444600_lvae085-B14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40618-021-01691-5","article-title":"The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial","volume":"45","author":"Soldat-Stankovi\u0107","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024082910341444600_lvae085-B15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17446651.2019.1556094","article-title":"Cardiometabolic risks in PCOS: a review of the current state of knowledge","volume":"14","author":"Kakoly","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2024082910341444600_lvae085-B16","volume-title":"IBM SPSS Statistics For Windows, Version 28.0","author":"IBM Corp","year":"2021"},{"key":"2024082910341444600_lvae085-B17","volume-title":"RStudio: Integrated Development for R","author":"RStudio Team","year":"2020"},{"key":"2024082910341444600_lvae085-B18","doi-asserted-by":"crossref","first-page":"e49220","DOI":"10.2196\/49220","article-title":"Appraising unmet needs and misinformation spread about polycystic ovary syndrome in 85,872 YouTube comments over 12 years: big data infodemiology study","volume":"25","author":"Malhotra","year":"2023","journal-title":"J Med Internet Res"},{"key":"2024082910341444600_lvae085-B19","doi-asserted-by":"crossref","first-page":"1084047","DOI":"10.3389\/fendo.2022.1084047","article-title":"Top 100 #PCOS influencers: understanding who, why and how online content for PCOS is influenced","volume":"13","author":"Elhariry","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024082910341444600_lvae085-B20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2024082910341444600_lvae085-B21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.fertnstert.2012.07.1057","article-title":"Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome","volume":"98","author":"Lerchbaum","year":"2012","journal-title":"Fertil Steril"},{"issue":"7","key":"2024082910341444600_lvae085-B22","first-page":"78","article-title":"Steroid mass spectrometry for the diagnosis of PCOS","volume":"7","author":"Keevil","year":"2019","journal-title":"Med Sci (Basel)"},{"issue":"3","key":"2024082910341444600_lvae085-B23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024082910341444600_lvae085-B24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","article-title":"Anti-M\u00fcllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population","volume":"39","author":"Bozdag","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"2024082910341444600_lvae085-B25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"issue":"5","key":"2024082910341444600_lvae085-B26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"issue":"5","key":"2024082910341444600_lvae085-B27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.fertnstert.2022.03.008","article-title":"Cardiometabolic biomarkers in women with polycystic ovary syndrome","volume":"117","author":"van der Ham","year":"2022","journal-title":"Fertil Steril"},{"issue":"6","key":"2024082910341444600_lvae085-B28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000526722","article-title":"History of polycystic ovary syndrome, premature adrenarche, and hyperandrogenism in pediatric endocrinology","volume":"95","author":"Witchel","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2024082910341444600_lvae085-B29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2024082910341444600_lvae085-B30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12020-021-02801-2","article-title":"Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies","volume":"74","author":"Anagnostis","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"2024082910341444600_lvae085-B31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/biomedicines10061455","article-title":"Prospective risk of type 2 diabetes in normal weight women with polycystic ovary syndrome","volume":"10","author":"Glintborg","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"2024082910341444600_lvae085-B32","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2024082910341444600_lvae085-B33","doi-asserted-by":"crossref","first-page":"e0226074","DOI":"10.1371\/journal.pone.0226074","article-title":"Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe","volume":"14","author":"Piltonen","year":"2019","journal-title":"PLoS One"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae085\/58732240\/lvae085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/134\/58814748\/lvae085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/134\/58814748\/lvae085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:27:39Z","timestamp":1724934459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/2\/134\/7727274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae085","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,8]]}}}